The Blood Cancer UK PhD Studentships 2026–2027 offer £150,000 per award to support doctoral training in blood cancer research. Projects can address any blood cancer type and must focus on prevention, early detection, predicting patient outcomes, or treatment.
The scheme supports discovery and translational research, as well as projects linked to ongoing clinical trials. Each proposal should explain how the research environment, supervision and training plan will help the student develop as a blood cancer researcher.
Eligibility Criteria
- The lead supervisor must apply as the lead applicant and be based at a UK university, hospital or other recognised research institution.
- Lead applicants should normally hold a permanent or long-term rolling contract with salary support for the full award period.
- Early career researchers may lead an application if a fellowship or another grant guarantees their salary throughout the studentship.
- Each application must include at least one co-supervisor. If an early career researcher leads, at least one co-supervisor must hold a tenured position at the host institution.
- The lead supervisor may name a student in the application or recruit one after receiving the award.
- Projects must align with at least one of Blood Cancer UK’s research priorities. Funding cannot primarily support the design or delivery of a clinical trial.
Funding Details
- Award: £150,000 per studentship.
- Duration: Three to six years, with full-time or part-time study options.
- Number of awards: Up to four planned for this round.
- Eligible costs: Student stipend at or above UKRI rates, tuition at the UK home fee rate, research costs and conference travel.
Deadline
- Application deadline: December 3, 2026, at 3:00 p.m. GMT.
- Expected decisions: March 2027.
- Check your institution’s internal deadline and allow time for signatory approval before submitting.
Further Information
- Official programme page and applicant guidance
- Blood Cancer UK Grants Portal